Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Capital Rx
AddedFeb 13, 2024
UpdatedJun 18, 2026
Capital Rx

Capital Rx

Series D

Capital Rx: A health tech firm transforming pharmacy benefits via its digital platform, JUDI™.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees
News
Website

Founded with the mission to transform the pharmacy benefits industry, Capital Rx leverages its advanced enterprise pharmacy platform, JUDI™, to digitally connect providers, patients, pharmacies, and plans. This integration aims to deliver the highest standard of clinical care while establishing a competitive marketplace for drug pricing. Capital Rx focuses on transparency and efficiency in pharmacy benefits management, targeting a broad market that includes employers, health plans, and government entities.

Notable figures affiliated with Capital Rx include its leadership team and key investors who have supported its innovative approach to healthcare. The company has achieved significant milestones, such as the successful implementation of JUDI™ across various healthcare sectors and recognition for its impact on reducing drug costs and improving patient outcomes. Capital Rx continues to make a substantial impact on the healthcare industry by promoting transparency and efficiency in pharmacy benefits management.

Capital Rx - Quick Facts

When was Capital Rx founded?

Capital Rx was founded in 2017.

Where is Capital Rx's headquarters located?

Capital Rx's headquarters is located in New York City, NY, US.

When was Capital Rx's last funding round?

Capital Rx's most recent funding round was for $50M (USD) in October 2023.

How much has Capital Rx raised to-date?

As of Oct 11, 2023, Capital Rx has raised a total of $253M (USD).

How many employees does Capital Rx have?

Capital Rx has 517 employees as of Feb 5, 2024.

Capital Rx - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Pharmacy Benefits
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities